Market Highlights
The Real-Time PCR (qPCR)
Market Outlook and Analysis by Product
(Reagents & Consumables, Instruments, Software & Services), Application
(Clinical, Research, and Forensics), End User (Hospitals &Diagnostic
Centers, Research Laboratories & Academic Institutes, Pharmaceutical &
Biotechnology Companies, Clinical Research Organizations, and Forensic
Laboratories) - Forecast till 2027
According to MRFR analysis, the global real-time PCR (qPCR)
market is expected to register a CAGR of ~8.92 from 2020 to 2027 and hold a value of ~USD 8,398.55
million by 2027.
The global real-time PCR market is driven by continued efforts by
PCR manufacturers to develop novel kits and systems to be used in molecular
diagnostic testing. For example, in January 2019, Qiagen N.V.(Germany)
developed next-generation qPCR systems, which were launched in April 2020. The
new system isprojected to offer highly automated workflowand quick turnaround
time. This factor is likely to provide a significant competitive advantage to
the company, fueling the overall market growth of Real-time PCR (qPCR).
Severalglobal and local market players dominate the global
real-time PCR (qPCR) market, contributing to a substantial market share. The
prominent players are engaged in organic and inorganic strategies such
asagreements, new product development & launches, and approval from
government authorities, joint ventures, mergers & acquisitions, and
partnerships to sustaintheir market positions.For instance, in October 2017,
AOAC International (US), independent standards developing organization
certified Bio-Rad Laboratories (US) iQ-Check Real-time PCR (qPCR) Kit as the
Official Method of Analysis for Salmonella species identification in raw meat.
Such recognition to the company is anticipated to boost the market growth.
Regional Analysis
Based on region, North America is expectedto dominate the global
real-time PCR (qPCR) market in 2020 due to the rising adoption of novel and
innovative genomic analysis products and the availability of R&D grants.
The high prevalence of chronic & infectious diseases coupled
with increasing awareness among patients about early diagnosis of diseases is propelling
the market growth.
Europe is expected to hold the second-largest position in the
global real-time PCR (qPCR) market in 2021. Key factors attributing to the
market growth are increasing adoption of real-time PCR (qPCR) to diagnose and
estimate disease-causing microbes, with increasing product availability
forconsumers.
Furthermore, the growth in the rest of the world real-time PCR
(qPCR) market is attributed to the technological product advancements and high
penetration of advanced healthcare technologies in research organizations
focused on adopting real-time PCR (qPCR) as a testing methodin Saudi Arabia,
the UAE, and the other Middle Eastern and African countries. Developing
countries such as Brazil, Colombia, and Argentina, among others in Latin America,
are also key contributors to the growth of the market.
Segmentation
The global real-time PCR (qPCR) market share has been segmented into type,
product, source, and application.
By product, the market has been segregated into reagents &
consumables, instruments, and software & services. The reagents &
consumables segment is expected to hold a considerable share of the market in
2021. Increasing adoption of reagents and consumables
Based on application,the real-time PCR (qPCR)market is
classified into clinical, research, forensics, and others. The clinical segment
held the largest market share in 2020. Some of the key factors attributing to
the market growth include the increasing adoption of Real-time PCR (qPCR) to
diagnose and estimate disease-causing microbes and other clinical ailments.
On the basis of the end user,the real-time PCR (qPCR) market is
segmented into hospitals & diagnostic centers, research laboratories &
academic institutes, pharmaceutical & biotechnology companies, clinical
research organizations, and forensic laboratories. The research laboratories
& academic institutes segment accounted for the major share in 2020 among
the end user segment of the global real-time PCR (qPCR) market due tothe
increasing number of research laboratories and rising application of Real-time
PCR (qPCR) in sectors such as stem cell research and genetic disease and
oncology research.
Key Players
Some of the key players in the global real-time PCR
(qPCR)marketareABL SA Group (Luxembourg), Agilent Technologies, Inc. (US),
Analytik Jena AG (Germany), BD (US), Bio-Rad Laboratories, Inc. (US), F.
Hoffmann-La Roche Ltd (Switzerland), Fluidigm Corporation (US), Lumex
Instruments (US), Primerdesign Ltd (UK), QIAGEN (Germany), Takara Bio Inc.
(Japan), Thermo Fisher Scientific (US), TOYOBO Inc. (Japan), and Vela
Diagnostics (Singapore).
About
Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment